Hemostasis Devices Market Size, Share, and COVID-19 Impact Analysis-Global-2022-2028-MedCore-Includes: Hemostasis Probes, Ligation Devices, and 1 more

Hemostasis Devices Market Size, Share, and COVID-19 Impact Analysis-Global-2022-2028-MedCore-Includes: Hemostasis Probes, Ligation Devices, and 1 more

The total global hemostasis device market is growing at a rate of almost 5%, which will take the 2021 market value of $689 million up to $940 million by 2028.

The full report suite on the global market for hemostasis devices includes hemostasis probes, ligation devices and sclerotherapy needles.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers

COVID-19 Impact Analysis

Market Drivers & Limiters
Market Forecasts Until 2028, and Historical Data to 2018
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

PROCEDURE NUMBERS

Due to the continual population growth, the number of procedures is expected to increase as well. Additionally, as the global population ages, the percentage of the population that is more prone to gastrointestinal bleeding is expected to rise, further increasing the number of procedures performed.

GLOBAL HEMOSTASIS DEVICE MARKET TRENDS

Diseases such as cirrhosis and hepatitis have become prevalent as the global population continues to age. These diseases tend to cause gastrointestinal bleeding and, in order to assist,hemostasis devices must be utilized.

GLOBAL HEMOSTASIS DEVICE MARKET SHARE INSIGHTS

Overall, within the global hemostasis device market there are three dominant competitors: Boston Scientific, Cook Medical, and Micro-Tech Endoscopy. In 2021, the leading competitor in the hemostasis device market was Boston Scientific. The company held share across all segments. After the launch of the Resolution 360™ ligation clip in 2016, the company added the Resolution 360™ ULTRA to its product portfolio in November 2020, cementing its leading market share even further.

GLOBAL HEMOSTASIS DEVICE MARKET SEGMENTATION SUMMARY

Hemostasis Probes
Ligation Devices
Sclerotherapy Needles

RESEARCH SCOPE SUMMARY

Regions – North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year – 2021
Forecast – 2022-2028
Historical Data – 2018-2021
Quantitative Coverage – Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage – COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources – Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE iDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail - It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

Work with us, and you’ll work with seasoned professionals – vigilant of deadlines, and committed to providing the most up-to-date, accurate medical device market research.